Prince Harry and Meghan Call on Big Pharma CEOs

On 06/05/2021, Prince Harry and Meghan, the Duke and Duchess of Sussex, issued an open letter addressed to the chief executive officers of five major pharmaceutical companies, urging immediate action to improve global access to COVID-19 vaccines. The letter was part of a broader international push to address disparities in vaccine distribution, particularly affecting low- and middle-income countries during the pandemic. The appeal called on companies including Pfizer, Moderna, AstraZeneca, Johnson & Johnson, and Novavax to temporarily waive intellectual property protections and share vaccine technology to expand manufacturing capacity worldwide. The Duke and Duchess emphasized that global vaccination efforts were being hindered by unequal access, with wealthier nations securing large supplies while many countries faced shortages. Their message echoed ongoing campaigns by organizations such as the People’s Vaccine Alliance, which advocated for more equitable distribution of vaccines and resources. In the letter, they highlighted the urgency of scaling up production and removing barriers to access, stressing that the global response to COVID-19 required coordinated action between governments, pharmaceutical companies, and international institutions. Their involvement added to a growing list of public figures and leaders supporting calls for policy changes to accelerate vaccine availability across regions. The initiative formed part of Prince Harry and Meghan’s wider engagement in global health advocacy throughout 2021, as they continued to use their platform to address issues related to pandemic response and healthcare equity.